Fidelity Investments’s GenMark Diagnostics, Inc GNMK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q2 | – | Sell |
-79,997
| Closed | -$1.91M | – | 5209 |
|
|
2021
Q1 | $1.91M | Sell |
79,997
-10,678,662
| -99% | -$198M | ﹤0.01% | 2479 |
|
|
2020
Q4 | $157M | Buy |
10,758,659
+97,961
| +0.9% | +$1.3M | 0.01% | 846 |
|
|
2020
Q3 | $151M | Buy |
10,660,698
+209,435
| +2% | +$3.2M | 0.02% | 741 |
|
|
2020
Q2 | $154M | Buy |
10,451,263
+1,334,883
| +15% | +$13.6M | 0.02% | 706 |
|
|
2020
Q1 | $37.6M | Buy |
9,116,380
+407,323
| +5% | +$1.91M | 0.01% | 1138 |
|
|
2019
Q4 | $41.9M | Buy |
8,709,057
+93,158
| +1% | +$514K | ﹤0.01% | 1283 |
|
|
2019
Q3 | $52.2M | Buy |
8,615,899
+61,617
| +0.7% | +$385K | 0.01% | 1150 |
|
|
2019
Q2 | $55.5M | Buy |
8,554,282
+83,419
| +1% | +$588K | 0.01% | 1172 |
|
|
2019
Q1 | $60.1M | Buy |
8,470,863
+77,571
| +0.9% | +$511K | 0.01% | 1133 |
|
|
2018
Q4 | $40.8M | Buy |
8,393,292
+30,334
| +0.4% | +$158K | 0.01% | 1233 |
|
|
2018
Q3 | $61.5M | Buy |
8,362,958
+51,098
| +0.6% | +$375K | 0.01% | 1162 |
|
|
2018
Q2 | $53M | Buy |
8,311,860
+37,248
| +0.5% | +$246K | 0.01% | 1251 |
|
|
2018
Q1 | $45M | Buy |
8,274,612
+55,353
| +0.7% | +$275K | 0.01% | 1343 |
|
|
2017
Q4 | $34.3M | Buy |
8,219,259
+19,147
| +0.2% | +$115K | ﹤0.01% | 1472 |
|
|
2017
Q3 | $79M | Buy |
8,200,112
+179,610
| +2% | +$1.87M | 0.01% | 1081 |
|
|
2017
Q2 | $94.9M | Buy |
8,020,502
+962,822
| +14% | +$12.3M | 0.01% | 1012 |
|
|
2017
Q1 | $90.5M | Buy |
7,057,680
+97,034
| +1% | +$1.17M | 0.01% | 1029 |
|
|
2016
Q4 | $85.2M | Buy |
6,960,646
+511,563
| +8% | +$6.08M | 0.01% | 1076 |
|
|
2016
Q3 | $76.1M | Buy |
6,449,083
+30,945
| +0.5% | +$299K | 0.01% | 1110 |
|
|
2016
Q2 | $55.8M | Buy |
6,418,138
+4,817
| +0.1% | +$33K | 0.01% | 1229 |
|
|
2016
Q1 | $33.8M | Buy |
6,413,321
+47,213
| +0.7% | +$263K | ﹤0.01% | 1417 |
|
|
2015
Q4 | $49.4M | Buy |
6,366,108
+8,729
| +0.1% | +$67.1K | 0.01% | 1262 |
|
|
2015
Q3 | $50M | Buy |
6,357,379
+38,162
| +0.6% | +$353K | 0.01% | 1246 |
|
|
2015
Q2 | $57.3M | Buy |
6,319,217
+36,920
| +0.6% | +$372K | 0.01% | 1282 |
|
|
2015
Q1 | $81.5M | Buy |
6,282,297
+22,152
| +0.4% | +$290K | 0.01% | 1121 |
|
|
2014
Q4 | $85.2M | Buy |
6,260,145
+890
| +0% | +$9.95K | 0.01% | 1084 |
|
|
2014
Q3 | $56.1M | Sell |
6,259,255
-26,700
| -0.4% | -$287K | 0.01% | 1251 |
|
|
2014
Q2 | $85M | Hold |
6,285,955
| – | – | 0.01% | 1095 |
|
|
2014
Q1 | $62.5M | Buy |
6,285,955
+63,516
| +1% | +$789K | 0.01% | 1220 |
|
|
2013
Q4 | $82.8M | Buy |
6,222,439
+168,881
| +3% | +$2.05M | 0.01% | 1066 |
|
|
2013
Q3 | $73.6M | Buy |
6,053,558
+1,138,000
| +23% | +$12.2M | 0.01% | 1096 |
|
|
2013
Q2 | $50.8M | Buy |
+4,915,558
| New | +$67.8M | 0.01% | 1236 |
|
Fidelity Investments's GNMK Position: Q2 2021 in Review
Fidelity Investments sold out of GenMark Diagnostics, Inc (GNMK) in Q2 2021, closing a stake of 79,997 shares — an estimated $1.91M sold.
Fidelity Investments first reported a position in GNMK in Q2 2013 and held it in 32 quarters. The position peaked at $157M in Q4 2020. 0 funds tracked by Wall St. Rank hold GNMK as of Q2 2021.
- Fidelity Investments reported no remaining GenMark Diagnostics, Inc position as of Q2 2021 after selling out during the quarter.
- Fidelity Investments sold 79,997 GenMark Diagnostics, Inc shares in Q2 2021, an estimated $1.91M.
- Fidelity Investments first reported a position in GenMark Diagnostics, Inc in Q2 2013 and held it in 32 quarters.
- Fidelity Investments's GenMark Diagnostics, Inc position peaked at $157M in Q4 2020.
- 0 funds tracked by Wall St. Rank held GenMark Diagnostics, Inc as of Q2 2021.
Based on Fidelity Investments's 13F filing for Q2 2021, filed 13 Aug 2021.